InterAx Biotech
PrivateLast Round
Grant
Nov 10, 2023
Total Funding Raised
$3.79M
Company Overview
InterAx Biotech operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Grant round in November 2023.
InterAx Biotech is a biotechnology company that has developed a drug discovery platform integrating mathematical modeling, artificial intelligence, and experimental methods to design and select novel drugs targeting G protein-coupled receptors (GPCRs).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterAx Biotech Comparables
Compare InterAx Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaMol Science | 86% | |
| Confo Therapeutics | 81% | |
| Abalone Bio | 78% |
For institutional investors. Book with your work email.
InterAx Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 10, 2023 | ||||
| Series A | Jan 15, 2019 | ||||
| Seed | Dec 6, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InterAx Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Verve Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 65% MoM.
- May 4, 2025
Monthly visitors increased 600% MoM.
For institutional investors. Book with your work email.
InterAx Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InterAx Biotech's valuation, stock price, and market status.
Is InterAx Biotech a public or private company?
InterAx Biotech is a private company.
What is the current stock price of InterAx Biotech?
InterAx Biotech is a private company, so its shares have no public market price. Caplight tracks InterAx Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InterAx Biotech worth (valuation)?
Valuation information for InterAx Biotech is not publicly available.
Can I buy InterAx Biotech stock?
InterAx Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InterAx Biotech's last funding round?
InterAx Biotech's most recent funding round was Grant on November 10, 2023.
Who are the main investors in InterAx Biotech?
Key investors in InterAx Biotech include Verve Ventures.
Will InterAx Biotech IPO soon?
No public IPO plans have been announced for InterAx Biotech.
How can I track InterAx Biotech secondary market activity?
Caplight tracks bids, offers, and trades in InterAx Biotech's shares on secondary markets.